Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Read More…
Industry, Sector and Symbol
Industry Sanitary services
Sub-IndustryEnvironmental & Facilities Services
SectorBusiness Services
Phone847-367-5910
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.49 billion
Profitability
Miscellaneous
Employees22,500
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) posted its earnings results on Thursday, August, 1st. The business services provider reported $0.56 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.83 by $0.27. The business services provider earned $845.80 million during the quarter, compared to the consensus estimate of $843.95 million. Stericycle had a positive return on equity of 10.90% and a negative net margin of 10.73%. The business's revenue was down 4.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.17 earnings per share. View Stericycle's Earnings History.
When is Stericycle's next earnings date?
What guidance has Stericycle issued on next quarter's earnings?
Stericycle updated its FY19 earnings guidance on Thursday, August, 1st. The company provided EPS guidance of $2.50-2.85 for the period, compared to the Thomson Reuters consensus estimate of $3.28. The company issued revenue guidance of $3.345-3.405 billion, compared to the consensus revenue estimate of $3.39 billion.
What price target have analysts set for SRCL?
6 brokerages have issued 12-month price objectives for Stericycle's shares. Their forecasts range from $44.00 to $66.00. On average, they expect Stericycle's share price to reach $51.80 in the next year. This suggests a possible upside of 2.9% from the stock's current price. View Analyst Price Targets for Stericycle.
What is the consensus analysts' recommendation for Stericycle?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Stericycle.
What are Wall Street analysts saying about Stericycle stock?
Here are some recent quotes from research analysts about Stericycle stock:
- 1. According to Zacks Investment Research, "Stericycle’s first-quarter 2019 earnings and revenues lagged the Zacks Consensus Estimate. Decline in Communication and Related Services businesses is weighing on Stericycle’s top line. A highly-competitive waste management industry will put Stericycle under pricing pressure. Global presence exposes Stericycle to foreign currency exchange rate risks. High debt may limit the company’s future expansion and worsen its risk profile. The stock has under performed its industry in the past six months. Despite such headwinds, Stericycle is making progress with Business Transformation initiatives, aimed at improving long-term operational and financial performance. The company continues to increase its market share and expand geographic base with the help of acquisitions. Stericycle's focus on providing regulated business-to-business services to smaller businesses should expand its offerings and boost the company's profits." (5/7/2019)
- 2. Robert W. Baird analysts commented, "Driven by the successful turnaround efforts at Terminix and solid performance in FSG, adjusted EBITDA of $105M was in line with our estimate and beat the Street’s $101M estimate; revenues of $496M also beat our/Street’s $489M/$486M estimates. Management raised FY2018 revenue guidance to $1,885-1,900M ($1,875M-$1,890M previously), owing to the transformation efforts and performance of acquisitions at Terminix. The company reiterated adjusted EBITDA guidance of $425-435M, as it continues to invest in the business to create sustainable, long-term growth. Maintain Outperform." (11/6/2018)
Has Stericycle been receiving favorable news coverage?
Media stories about SRCL stock have trended somewhat negative on Sunday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stericycle earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Stericycle.
Who are some of Stericycle's key competitors?
What other stocks do shareholders of Stericycle own?
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Ms. Cindy J. Miller, Pres, CEO & Director (Age 56)
- Mr. Daniel V. Ginnetti, Exec. VP & CFO (Age 50)
- Mr. Kurt M. Rogers, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
- Ms. Ruth-Ellen Abdulmassih, Advisor (Age 57)
- Mr. Richard Joseph Hoffman, Sr. VP & Chief Accounting Officer (Age 52)
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (10.09%), Vanguard Group Inc. (8.61%), BlackRock Inc. (8.33%), BlackRock Inc. (8.33%), Baillie Gifford & Co. (5.90%) and Clarkston Capital Partners LLC (4.47%). Company insiders that own Stericycle stock include Brian P Anderson, Charles A Alutto, Daniel Ginnetti, Jack W Schuler, John Patience, Mark C Miller and Thomas D Brown. View Institutional Ownership Trends for Stericycle.
Which institutional investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Price T Rowe Associates Inc. MD, Vanguard Group Inc., Invesco Ltd., SG Americas Securities LLC, Global Thematic Partners LLC, River & Mercantile Asset Management LLP and Tamarack Advisers LP. View Insider Buying and Selling for Stericycle.
Which institutional investors are buying Stericycle stock?
SRCL stock was acquired by a variety of institutional investors in the last quarter, including Ontario Teachers Pension Plan Board, Brown Advisory Inc., Nuveen Asset Management LLC, Kohlberg Kravis Roberts & Co. L.P., Sasco Capital Inc. CT, UBS Asset Management Americas Inc., Teacher Retirement System of Texas and Kirr Marbach & Co. LLC IN. Company insiders that have bought Stericycle stock in the last two years include Brian P Anderson and Jack W Schuler. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $50.33.
How big of a company is Stericycle?
Stericycle has a market capitalization of $4.59 billion and generates $3.49 billion in revenue each year. The business services provider earns $-244,700,000.00 in net income (profit) each year or $4.45 on an earnings per share basis. Stericycle employs 22,500 workers across the globe.View Additional Information About Stericycle.
What is Stericycle's official website?
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe SRCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
